Papamarkou Wellner Asset Management’s AbbVie ABBV Stock Holding History

Papamarkou Wellner Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.19M	Buy	10,063 +452	+5%	+$100K	1.34%	25
2025 Q4	$2.2M	Buy	9,611 +52	+0.5%	+$11.8K	1.32%	24
2025 Q3	$2.21M	Hold	9,559	–	–	1.37%	24
2025 Q2	$1.77M	Buy	9,559 +1,098	+13%	+$204K	1.17%	29
2025 Q1	$1.77M	Sell	8,461 -582	-6%	-$113K	1.23%	30
2024 Q4	$1.61M	Buy	+9,043	New	+$1.66M	1.11%	33

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Papamarkou Wellner Asset Management's ABBV Position: Q1 2026 in Review

Papamarkou Wellner Asset Management increased its AbbVie (ABBV) stake by 4.7% in Q1 2026, buying an estimated $100K and bringing the position to 10,063 shares worth $2.19M. The position accounts for 1.34% of the portfolio, ranked #25.

Papamarkou Wellner Asset Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.21M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Papamarkou Wellner Asset Management held 10,063 shares of AbbVie worth $2.19M as of Q1 2026.
Papamarkou Wellner Asset Management bought 452 AbbVie shares in Q1 2026, an estimated $100K.
AbbVie made up 1.34% of Papamarkou Wellner Asset Management's portfolio in Q1 2026, its #25 holding.
Papamarkou Wellner Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Papamarkou Wellner Asset Management's AbbVie position peaked at $2.21M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Papamarkou Wellner Asset Management's 13F filing for Q1 2026, filed 15 May 2026.